during the swiftly evolving area of oncology exploration, accurate and efficient mutation screening is important for building qualified therapies. The KRAS providers Platform performs a pivotal position During this landscape by offering comprehensive solutions for KRAS mutation profiling and Examination. KRAS mutations, located in close to ninety f